NCT01067287 Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT01066663 Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT01065662 AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies Status COMPLETED Phase PHASE1
NCT01063010 Pilot Study of Bevacizumab (Avastin) in Patients With Septic Shock Status WITHDRAWN Phase NA
NCT01058655 RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01040754 fMRI Study of Expectancy on Acupuncture Treatment Outcomes in Knee OA Status COMPLETED Phase NA
NCT01010191 Harnessing Placebo Effects: Non-Deceptive Use of Placebo in Irritable Bowel Syndrome (IBS) Status COMPLETED Phase NA
NCT01009788 ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer Status COMPLETED Phase PHASE2
NCT01004172 Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases Status COMPLETED Phase PHASE2
NCT00997529 Mini Allo Stem Cell Transplantation for the Treatment of Solid Tumors Status COMPLETED Phase NA
NCT00997334 Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC Status COMPLETED Phase PHASE2
NCT00973752 Treatment of Older Adults With Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT00953576 Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer Status TERMINATED Phase PHASE1/PHASE2